Contents
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued), Volume 1 - Number 1
Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma
, 1(1): 2 - 10Lawren C. Wu, Joseph R. Arron, Jeffrey M. Harris, John G. Matthews and Karin Rosen
DOI: 10.2174/2212703801999131206110837
Cells and Mediators of Inflammation in Acute Pancreatitis
, 1(1): 11 - 23Ramesh Kumar and Madhav Bhatia
DOI: 10.2174/2212703801999131206110914
Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
, 1(1): 24 - 31Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu
DOI: 10.2174/22127038114019990003
In Vitro Analysis of Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis as a Possible Predictable Marker of TNF-alpha Blockers
, 1(1): 32 - 38Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada
DOI: 10.2174/22127038114016660004
Synthesis and Pharmacological Studies of Novel 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents
, 1(1): 39 - 44Mayura A. Kale, Ashok S. Narute and Tukaram M. Kalyankar
DOI: 10.2174/2212703801666131209232632
Activin-A: A New Piece in the Puzzle of Tolerance in Asthma
, 1(1): 45 - 56Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aikaterini I Trochoutsou and Georgina Xanthou
DOI: 10.2174/2212703801666140221004020
Hydrogen Sulfide: A New Tool to Design and Develop Drugs
, 1(1): 57 - 66Nethaji Muniraj, Abel Damien Ang, Alireza Badiei, Jack Rivers-Auty and Madhav Bhatia
DOI: 10.2174/2212703801666140311005131
Webmaster Contact: info@benthamscience.net